BCRX Annual Interest Expense
$108.24 M
+$9.15 M+9.23%
31 December 2023
Summary:
As of January 22, 2025, BCRX annual interest expense is $108.24 million, with the most recent change of +$9.15 million (+9.23%) on December 31, 2023. During the last 3 years, it has risen by +$93.74 million (+646.42%). BCRX annual interest expense is now at all-time high.BCRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Quarterly Interest Expense
$24.83 M
+$95.00 K+0.38%
30 September 2024
Summary:
As of January 22, 2025, BCRX quarterly interest expense is $24.83 million, with the most recent change of +$95.00 thousand (+0.38%) on September 30, 2024. Over the past year, it has increased by +$245.00 thousand (+1.00%). BCRX quarterly interest expense is now -14.13% below its all-time high of $28.91 million, reached on June 30, 2023.BCRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX TTM Interest Expense
$98.65 M
-$2.52 M-2.49%
30 September 2024
Summary:
As of January 22, 2025, BCRX TTM interest expense is $98.65 million, with the most recent change of -$2.52 million (-2.49%) on September 30, 2024. Over the past year, it has dropped by -$9.59 million (-8.86%). BCRX TTM interest expense is now -10.41% below its all-time high of $110.11 million, reached on September 30, 2023.BCRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.2% | +1.0% | -8.9% |
| 3 y3 years | +646.4% | +75.9% | +113.9% |
| 5 y5 years | +1079.6% | +715.6% | +729.5% |
BCRX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.5% | -14.1% | +32.2% | -10.4% | +66.4% |
| 5 y | 5-year | at high | +810.2% | -14.1% | +750.9% | -10.4% | +729.5% |
| alltime | all time | at high | -14.1% | -10.4% |
BioCryst Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.83 M(+0.4%) | $98.65 M(-2.5%) |
| June 2024 | - | $24.73 M(+0.9%) | $101.17 M(-4.0%) |
| Mar 2024 | - | $24.51 M(-0.3%) | $105.35 M(-2.7%) |
| Dec 2023 | $108.24 M(+9.2%) | $24.58 M(-10.1%) | $108.24 M(-1.7%) |
| Sept 2023 | - | $27.34 M(-5.4%) | $110.11 M(+2.4%) |
| June 2023 | - | $28.91 M(+5.5%) | $107.54 M(+4.8%) |
| Mar 2023 | - | $27.40 M(+3.5%) | $102.65 M(+3.6%) |
| Dec 2022 | $99.09 M(+67.1%) | $26.46 M(+6.8%) | $99.09 M(+8.4%) |
| Sept 2022 | - | $24.77 M(+3.1%) | $91.41 M(+13.2%) |
| June 2022 | - | $24.02 M(+0.8%) | $80.75 M(+15.0%) |
| Mar 2022 | - | $23.84 M(+26.9%) | $70.23 M(+18.4%) |
| Dec 2021 | $59.29 M(+308.9%) | $18.78 M(+33.0%) | $59.29 M(+28.6%) |
| Sept 2021 | - | $14.12 M(+4.6%) | $46.12 M(+30.9%) |
| June 2021 | - | $13.49 M(+4.6%) | $35.25 M(+42.9%) |
| Mar 2021 | - | $12.90 M(+130.1%) | $24.67 M(+66.5%) |
| Dec 2020 | $14.50 M(+21.9%) | $5.61 M(+73.2%) | $14.81 M(+20.5%) |
| Sept 2020 | - | $3.24 M(+11.0%) | $12.29 M(+1.6%) |
| June 2020 | - | $2.92 M(-4.2%) | $12.10 M(-1.0%) |
| Mar 2020 | - | $3.05 M(-1.3%) | $12.21 M(+2.7%) |
| Dec 2019 | $11.89 M(+29.6%) | $3.09 M(+1.4%) | $11.89 M(+6.0%) |
| Sept 2019 | - | $3.04 M(+0.3%) | $11.22 M(+6.6%) |
| June 2019 | - | $3.04 M(+11.3%) | $10.52 M(+8.7%) |
| Mar 2019 | - | $2.73 M(+12.9%) | $9.68 M(+5.5%) |
| Dec 2018 | $9.18 M(+7.1%) | $2.41 M(+2.9%) | $9.18 M(+2.0%) |
| Sept 2018 | - | $2.35 M(+6.9%) | $8.99 M(+2.3%) |
| June 2018 | - | $2.19 M(-1.2%) | $8.79 M(+1.2%) |
| Mar 2018 | - | $2.22 M(-0.4%) | $8.69 M(+1.4%) |
| Dec 2017 | $8.56 M | $2.23 M(+4.3%) | $8.56 M(+1.2%) |
| Sept 2017 | - | $2.14 M(+2.2%) | $8.46 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $2.09 M(-0.3%) | $7.79 M(+9.5%) |
| Mar 2017 | - | $2.10 M(-1.5%) | $7.12 M(+9.7%) |
| Dec 2016 | $6.49 M(+24.8%) | $2.13 M(+45.5%) | $6.49 M(+13.9%) |
| Sept 2016 | - | $1.47 M(+3.1%) | $5.69 M(+4.1%) |
| June 2016 | - | $1.42 M(-3.3%) | $5.47 M(+2.1%) |
| Mar 2016 | - | $1.47 M(+9.9%) | $5.36 M(+3.0%) |
| Dec 2015 | $5.20 M(+4.0%) | $1.34 M(+7.8%) | $5.20 M(+0.5%) |
| Sept 2015 | - | $1.24 M(-5.0%) | $5.18 M(+0.5%) |
| June 2015 | - | $1.31 M(-0.7%) | $5.15 M(+1.6%) |
| Mar 2015 | - | $1.31 M(+0.1%) | $5.07 M(+1.5%) |
| Dec 2014 | $5.00 M(+4.6%) | $1.31 M(+8.0%) | $5.00 M(+1.5%) |
| Sept 2014 | - | $1.22 M(-0.7%) | $4.93 M(+0.5%) |
| June 2014 | - | $1.23 M(-1.4%) | $4.90 M(+1.2%) |
| Mar 2014 | - | $1.24 M(0.0%) | $4.84 M(+1.3%) |
| Dec 2013 | $4.78 M(+2.4%) | $1.24 M(+4.3%) | $4.78 M(+1.3%) |
| Sept 2013 | - | $1.19 M(+2.2%) | $4.72 M(+0.5%) |
| June 2013 | - | $1.17 M(-1.3%) | $4.69 M(+0.1%) |
| Mar 2013 | - | $1.18 M(0.0%) | $4.69 M(+0.4%) |
| Dec 2012 | $4.67 M(+23.6%) | $1.18 M(+1.2%) | $4.67 M(+0.4%) |
| Sept 2012 | - | $1.17 M(+0.5%) | $4.65 M(+0.1%) |
| June 2012 | - | $1.16 M(0.0%) | $4.64 M(-0.1%) |
| Mar 2012 | - | $1.16 M(0.0%) | $4.65 M(+23.1%) |
| Dec 2011 | $3.77 M(>+9900.0%) | $1.16 M(0.0%) | $3.77 M(+44.4%) |
| Sept 2011 | - | $1.16 M(-0.5%) | $2.61 M(+79.8%) |
| June 2011 | - | $1.17 M(+304.9%) | $1.45 M(+404.9%) |
| Mar 2011 | - | $288.00 K(>+9900.0%) | $288.00 K(>+9900.0%) |
| Dec 2010 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00 | $0.00 |
FAQ
- What is BioCryst Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual interest expense year-on-year change?
- What is BioCryst Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly interest expense year-on-year change?
- What is BioCryst Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM interest expense year-on-year change?
What is BioCryst Pharmaceuticals annual interest expense?
The current annual interest expense of BCRX is $108.24 M
What is the all time high annual interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual interest expense is $108.24 M
What is BioCryst Pharmaceuticals annual interest expense year-on-year change?
Over the past year, BCRX annual interest expense has changed by +$9.15 M (+9.23%)
What is BioCryst Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of BCRX is $24.83 M
What is the all time high quarterly interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly interest expense is $28.91 M
What is BioCryst Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, BCRX quarterly interest expense has changed by +$245.00 K (+1.00%)
What is BioCryst Pharmaceuticals TTM interest expense?
The current TTM interest expense of BCRX is $98.65 M
What is the all time high TTM interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM interest expense is $110.11 M
What is BioCryst Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, BCRX TTM interest expense has changed by -$9.59 M (-8.86%)